|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 25/16 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) |
| (11) | Number of the document | 3378535 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18155441.1 |
| Date of filing the European patent application | 2012-10-26 | |
| (97) | Date of publication of the European application | 2018-09-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-01-04 |
| (46) | Date of publication of the claims translation | 2023-02-27 |
| (30) | Number | Date | Country code |
| 201161553131 P | 2011-10-28 | US | |
| 201261711208 P | 2012-10-08 | US |
| (72) |
SALDANHA, Jose , GB
NIJJAR, Tarlochan , US
|
| (73) |
Prothena Biosciences Limited ,
77 Sir John Rogerson's Quay, Block C
Grand Canal Docklands, Dublin 2, D02 VK60,
IE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Humanizuoti antikūnai, atpažįstantys alfa-sinukleiną |
| HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 14 | 289.00 EUR |
| 2026-10-26 |